Amlodipine Besylate Tablet
Product Images NDC 87441-017

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Amlodipine Besylate (NDC 87441-017). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Unit Dose Solutions, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Amlodipine 10 mg (8744101601 Amlodipine Besylate 10 mg)

Amlodipine 10 mg (8744101601 Amlodipine Besylate 10 mg)
Amlodipine Besylate tablets, USP 10 mg, oral dosage form, in a single-dose repackaged label format. The label includes the NDC 87441-016-01 and is labeled Rx only. It is repackaged by Unit Dose Solutions, Inc. and distributed by Tuckhoe Enterprises, LLC, with directions to dispense the accompanying medication guide and storage instructions between 20° to 25°C.*
FDA Label Image

Amlodipine 5mg (Amlodipine Besylate 5 mg)

Amlodipine 5mg (Amlodipine Besylate 5 mg)
Label for Amlodipine Besylate Tablets, USP 5 mg, oral dosage form. It includes NDC 87441-017-01 and instructions for pharmacists to dispense the Medication Guide. The label notes the storage temperature range and specifies repackaging by Unit Dose Solutions, Inc. with distribution by Tuckhoe Enterprises, LLC.*
FDA Label Image

Figure 2 (Amlodipine Fig)

Figure 2 (Amlodipine Fig)
A forest plot presenting hazard ratios with 95% confidence intervals comparing the effects of Amlodipine versus placebo across various patient subgroups. Subgroups include overall patients, age groups, gender, baseline sitting systolic blood pressure, baseline vessel disease, baseline vessels with stenosis, and PCI stent status. The plot visually displays subgroup comparisons with a reference line at hazard ratio 1.0, indicating no effect.*
FDA Label Image

Figure 1 (Amlodipine Gra)

Figure 1 (Amlodipine Gra)
This is a Kaplan-Meier survival curve comparing event rates over 24 months between Amlodipine and placebo groups. The x-axis shows time in months, and the y-axis shows the event rate. The graph includes hazard ratio and p-value data assessing statistical differences between the two groups.*
FDA Label Image

Amlodipine-str-2 (Amlodipine Str 2)

Amlodipine-str-2 (Amlodipine Str 2)
Chemical structure diagram of amlodipine besylate, showing the arrangement of its molecular components including a chlorinated ring, ester groups, and an amine side chain.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.